SY

Sapna Yadav

Active Director Director DIN 10057680
DIN 10057680 First appointment Feb 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Sapna Yadav

Data last updated:

Sapna Yadav is a Director at Naturamrit Pharma Private Limited (since 2023). The company operates in Paper. Naturamrit Pharma Private Limited reported revenue of ₹2.5 Lakh (FY 2025).

DIN 10057680
Primary Designation Director
Industry Paper
First Appointment 27 Feb 2023
Oldest Company Age 3 yrs
Largest company Naturamrit Pharma Private Limited · ₹2.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Naturamrit Pharma Private Limited U21003RJ2023PTC086117
Director27 Feb 20232023₹2.5 Lakh (FY 2025)Active

Board colleagues of Sapna Yadav

Directorship timeline

Open interactive timeline →
Naturamrit Pharma Private Limited
Premium access

Shareholding and investment profile for Sapna Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sapna Yadav

Sapna Yadav currently holds 1 directorship: Naturamrit Pharma Private Limited (Director, since 27 Feb 2023, revenue ₹2.5 Lakh (FY 2025)).

Sapna Yadav was first appointed on 27 Feb 2023 as Director at Naturamrit Pharma Private Limited.

The current boards of Sapna Yadav's companies include Rohit Pareek (Naturamrit Pharma Private Limited), Yogendra Singh Mawai (Naturamrit Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available